Soleno Therapeutics, Inc. · NASDAQ:SLNO
FMR LLC reported a 6.60% stake in Soleno Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 6, 2025
FMR LLC reported a 6.60% stake in Soleno Therapeutics, Inc., 3,337,858 shares, as a passive investor on Jun 30, 2025. Filed Aug 6, 2025 (Schedule 13G).
- Stake
- 6.60%
- Shares
- 3,337,858
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 6.60% | 3,337,858 |
| Abigail P. Johnson | 6.60% | 3,337,858 |
Source
Related
- Soleno Therapeutics, Inc.
- FMR LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 7, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026